Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bufei Huoxue Capsule for pneumoconiosis
ChiCTR2000032448Phase 4Recruiting
- Sponsor
- Shanghai Pulmonary Hospital
- Start
- May 2020
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bufei huoxue in pneumoconiosis, silicosis and coal workers' pneumoconiosis (CWP) (2 arms), sponsored by Shanghai Pulmonary Hospital. Primary endpoint: Forced vital capacity percent predicted. Started May 2020; status: recruiting.
02
Drugs
bufei huoxue
03
Conditions
pneumoconiosissilicosiscoal workers' pneumoconiosis (CWP)
Beyond the preview
Go deeper on ChiCTR2000032448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032448.